Publications - Page 18 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Transplantation pulmonaire
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.

Berrada KR, Belot A, Neven B, Ohlmann C, Tronc F, Rice G, Thouvenin G, Dubus JC, Mazenq J, Frémond ML, Stremler N, Soummer-Feuillet S, Cottin V, Reix P.

J Clin Immunol. 2023 Nov;43(8):2156-2164.
Pneumopathies interstitielles diffuses (PID)
Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?

Cottin V, Kolb M.

Eur Respir J. 2023 Nov 29;62(5):2301852.
Pneumopathies interstitielles diffuses (PID)
Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases

Walsh SLF, Lafyatis RA, Cottin V.

J Thorac Imaging. 2023 Nov 1;38(Suppl 1):S30-S37.
Hypertension pulmonaire (HTP)
Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.

Valdeolmillos E, Le Pavec J, Audié M, Savale L, Jais X, Montani D, Sitbon O, Feuillet S, Mercier O, Petit J, Humbert M, Fadel E, Belli E, Hascoët S.

J Thorac Cardiovasc Surg. 2023 Dec 3:S0022-5223(23)01121-2.
Hypertension pulmonaire (HTP)
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI).

Genet Med. 2023 Nov;25(11):100925.
Hypertension pulmonaire (HTP)
KCNK3 channel is important for the ventilatory response to hypoxia in rats.

Yegen CH, Lambert M, Beurnier A, Montani D, Humbert M, Planès C, Boncoeur E, Voituron N, Antigny F.

Respir Physiol Neurobiol. 2023 Dec;318:104164.
Hypertension pulmonaire (HTP)
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Mismetti V, Delavenne X, Montani D, Bezzeghoud S, Delezay O, Hodin S, Launay D, Marchand-Adam S, Nunes H, Ollier E, Reynaud-Gaubert M, Pastre J, Traclet J, Quetant S, Zeghmar S, Bertoletti L, Cottin V.

Respir Res. 2023 Nov 7;24(1):273.
Hypertension pulmonaire (HTP)
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Lechartier B, Kularatne M, Jaïs X, Humbert M, Montani D.

Semin Respir Crit Care Med. 2023 Dec;44(6):721-727.
Hypertension pulmonaire (HTP)
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.

Montani D, Antigny F, Jutant EM, Chaumais MC, Le Ribeuz H, Grynblat J, Khouri C, Humbert M.

ERJ Open Res. 2023 Nov 13;9(6):00350-2023.
Pneumopathies interstitielles diffuses (PID)
The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study.

Roeser A, Sese L, Chassagnon G, Chaigne B, Dunogue B, Tran Ba S, Jebri S, Brillet PY, Revel MP, Aubourg F, Dhote R, Caux F, Annesi-Maesano I, Mouthon L, Nunes H, Uzunhan Y.

Respir Res. 2023 Jun 8;24(1):151.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.

Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?

Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases

Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

KCNK3 channel is important for the ventilatory response to hypoxia in rats.

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Pulmonary hypertension associated with diazoxide: the SUR1 paradox.

The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study.